In the Reset Your Set Point program, a physician may prescribe patients tirzepatide compounded with B-12 and glycine and dispensed in a vial that allows for flexible dosing.
The cost of tirzepatide starts at $249 for a 6-8 week supply.
Tirzepatide is a GLP-1 receptor agonist and GIP (glucose-dependent insulinotropic polypeptide) receptor. It is commonly known by the brand names Mounjaro for type 2 diabetes and Zepbound for weight loss. It is taken as a weekly subcutaneous injection.
In clinical trials, the manufacturer of Mounjaro and Zepbound showed that patients taking tirzepatide in a 68-week study had weight loss results of
26% of their starting body weight.
The most common side effects of tirzepatide include nausea, diarrhea, and constipation, which typically lessen over time.
To learn if you might be eligible for weight loss treatment with tirzepatide, take our quick
online assessment.